Tofacitinib Adherence and Outcomes in Refractory Inflammatory Bowel Disease.
C Alex WilesNisha B ShahJake BellBaldeep S PablaElizabeth A ScovilleRobin L DalalDawn B BeaulieuDavid A SchwartzSara N HorstPublished in: Crohn's & colitis 360 (2021)
Adherence was high in a cohort with highly refractory disease.